Clinical Trials Arena December 11, 2024
Appropriately planning and conducting early phase clinical trials is critical to setting the stage for successful pivotal studies and, eventually, approval. But there are major challenges that organisers must bear in mind
As smaller, leaner organisations that must utilise resources carefully, biotechs face unique challenges as they enter clinical trials. These challenges are compounded by the fact that many biotechs are taking the lead in new and emerging modalities, from cell and gene therapies (CGTs) to antibody-drug conjugates and mRNA-based therapies — meaning that traditional approaches to clinical trials may not be the best option. Nevertheless, appropriately planning and conducting early phase clinical trials is critical to setting the stage for successful pivotal studies and, eventually, approval.
To better understand...
Today's Sponsors
Today's Sponsor